July 29, 2011
Interim report for the second quarter of 2011: Bayer continues positive momentum
Sales up 5.4 percent on an adjusted basis to EUR 9,252 million / Operating result (EBIT) advances 25.9 percent to EUR 1,273 million / EBITDA before special items increases by 5.8 percent to EUR 2,035 million / Net income rises by substantial 40.9 percent to EUR 747 million / Group outlook for 2011 confirmed / Significant progress with innovation projects / Efficiency measures advancing well
» more